Janis T. Fleming
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression.
Journal: Cancer research
Published: May 04, 2021
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Journal: Oncogene
Published: December 21, 2019
BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Journal: Oncogene
Published: June 21, 2019
Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.
Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.
Journal: EMBO molecular medicine
Published: March 16, 2018
Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.
Journal: BMC cancer
Published: August 26, 2014
Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Journal: European urology
Published: May 27, 2013
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.
Journal: The Journal of clinical investigation
Published: March 12, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026